Eurazeo (OTCPK:EUZO.F) - Stock Price, News & Analysis

Resumen acción EUZO.F

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buyins of a private company, and investments in mid-market and listed public companies.

Acerca de la empresa

EUZO.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	5/6
Financial Health	5/6
Dividends	3/6

Recompensas

Cotiza un 58.7% por debajo de nuestra estimación de su valor razonable

Se prevé un crecimiento anual de los ingresos de 24.91%

Los beneficios aumentaron un 147.1% el año pasado

Análisis de riesgos

Se prevé que los beneficios disminuyan una media de 46.6% al año durante los próximos 3 años.

Alto nivel de ganancias no monetarias

Acciones altamente ilíquidas

El dividendo de 3.14% no está bien cubierto por los flujos de caja

Competidores de Eurazeo SE

Metro Pacific Investments

OTCPK:MPCF.F

US$1.4b

Essent Group

NYSE:ESNT

US$5.7b

MGIC Investment

NYSE:MTG

US$5.3b

Jackson Financial

NYSE:JXN

US$4.9b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Eurazeo
Historical stock prices
Current Share Price	€58.64
52 Week High	€72.88
52 Week Low	€58.64
Beta	1.39
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-4.50%
3 Year Change	-11.39%
5 Year Change	-15.26%
Change since IPO	-16.30%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	EUZO.F	US Diversified Financial	Mercado US
7D	0%	-3.0%	-1.7%
1Y	-4.5%	21.5%	22.4%

Rentabilidad vs. Industria: EUZO.F obtuvo unos resultados inferiores a los del sector US Diversified Financial , que el año pasado arrojó un rendimiento del 20.4%.

Rentabilidad vs. Mercado: EUZO.F obtuvo unos resultados inferiores a los del mercado US, que fue del 24% el año pasado.

Volatilidad de los precios

Is EUZO.F's price volatile compared to industry and market?
EUZO.F volatility
EUZO.F Average Weekly Movement	n/a
Diversified Financial Industry Average Movement	5.7%
Market Average Movement	6.1%
10% most volatile stocks in US Market	16.6%
10% least volatile stocks in US Market	3.0%

Precio estable de las acciones: EUZO.F no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de EUZO.F en el último año.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1969	19,254	Christophe Baviere	www.eurazeo.com/en/

Resumen de fundamentos de Eurazeo SE

¿Cómo se comparan los beneficios e ingresos de Eurazeo con su capitalización de mercado?
Estadísticas fundamentales de EUZO.F
Capitalización bursátil	US$5.85b
Beneficios(TTM)	US$2.72b
Ingresos (TTM)	US$3.92b

2.2x

Ratio precio-beneficio (PE)

1.5x

Ratio precio-ventas (PS)

¿Está EUZO.F sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de EUZO.F
Ingresos	€3.58b
Coste de los ingresos	€347.26m
Beneficio bruto	€3.24b
Otros gastos	€747.75m
Beneficios	€2.49b

Últimos beneficios comunicados

Jun 30, 2023

Próxima fecha de beneficios

Mar 07, 2024

Beneficios por acción (BPA)	33.29
Margen bruto	90.31%
Margen de beneficio neto	69.44%
Ratio deuda/patrimonio	7.3%

¿Cómo se ha desempeñado EUZO.F a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

3.1%

Rentabilidad actual por dividendo

6%

Ratio de pagos

Resumen acción EUZO.F

Recompensas

Análisis de riesgos

Competidores de Eurazeo SE

OTCPK:MPCF.F

US$1.4b

NYSE:ESNT

US$5.7b

NYSE:MTG

US$5.3b

NYSE:JXN

US$4.9b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Recent updates

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.

Rentabilidad de los accionistas

Volatilidad de los precios

Acerca de la empresa

Resumen de fundamentos de Eurazeo SE

2.2x

1.5x

Beneficios e Ingresos

Dividendos

3.1%

6%